Characteristics of innate lymphoid cells (ILCs) and their role in immunological disorders (an update)

Cellular Immunology

Volumn 298, Issue 1-2, 2015, Pages 66-76

  Yazdani, Reza ^a,b   Sharifi, Mehri ^b   Shirvan, Aylar Saba ^c   Azizi, Gholamreza ^b,d   Ganjalikhani Hakemi, Mazdak ^a,e  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ALBORZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Autoimmunity; Inflammation; Innate lymphoid cells

Indexed keywords

ALLERGY; ASTHMA; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL PLASTICITY; HUMAN; IMMUNE DEFICIENCY; IMMUNOPATHOLOGY; INFLAMMATION; LYMPHOID CELL; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; REVIEW; HYPERSENSITIVITY; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE; LYMPHOID TISSUE; NATURAL KILLER CELL; SECRETION (PROCESS);

CYTOKINE;

AUTOIMMUNE DISEASES; CYTOKINES; HUMANS; HYPERSENSITIVITY; IMMUNITY, INNATE; KILLER CELLS, NATURAL; LYMPHOCYTES; LYMPHOID TISSUE;

EID: 84958634084     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2015.09.006     Document Type: Review

References (146)

1. Nowarski R., Gagliani N., Huber S., Flavell R.A. Innate immune cells in inflammation and cancer. Cancer Immunol. Res. 2013, 1(2):77-84.
2. Walker J.A., Barlow J.L., McKenzie A.N. Innate lymphoid cells - how did we miss them?. Nat. Rev. Immunol. 2013, 13(2):75-87.
3. Yamada H. Current perspectives on the role of IL-17 in autoimmune disease. J. Inflamm. Res. 2010, 3:33.
4. Tesmer L.A., Lundy S.K., Sarkar S., Fox D.A. Th17 cells in human disease. Immunol. Rev. 2008, 223(1):87-113.
5. Milner J.D., Brenchley J.M., Laurence A., Freeman A.F., Hill B.J., Elias K.M., et al. Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008, 452(7188):773-776.
6. Hwang Y.Y., McKenzie A.N. Innate Lymphoid Cells in Immunity and Disease. Crossroads between Innate and Adaptive Immunity IV 2013, Springer, p. 9-26.
7. Yokota Y., Mansouri A., Mori S., Sugawara S., Adachi S., Nishikawa S.-I., et al. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 1999, 397(6721):702-706.
8. Mebius R.E., Rennert P., Weissman I.L. Developing lymph nodes collect CD4+ CD3-LTβ+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 1997, 7(4):493-504.
9. Geremia A., Arancibia-Cárcamo C.V., Fleming M.P., Rust N., Singh B., Mortensen N.J., et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J. Exp. Med. 2011, 208(6):1127-1133.
10. Takayama T., Kamada N., Chinen H., Okamoto S., Kitazume M.T., Chang J., et al. Imbalance of NKp44+ NKp46- and NKp44- NKp46+ natural killer cells in the intestinal mucosa of patients with Crohn's disease. Gastroenterology 2010, 139(3):882-892. e3.
11. Spits H., Artis D., Colonna M., Diefenbach A., Di Santo J.P., Eberl G., et al. Innate lymphoid cells - a proposal for uniform nomenclature. Nat. Rev. Immunol. 2013, 13(2):145-149.
12. Kiessling R., Klein E., Pross H., Wigzell H. "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur. J. Immunol. 1975, 5(2):117-121.
13. Herberman R.B., Nunn M.E., Holden H.T., Lavrin D.H. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Int. J. Cancer 1975, 16(2):230-239.
14. Vivier E., Raulet D.H., Moretta A., Caligiuri M.A., Zitvogel L., Lanier L.L., et al. Innate or adaptive immunity? The example of natural killer cells. Science 2011, 331(6013):44-49.
15. Cella M., Fuchs A., Vermi W., Facchetti F., Otero K., Lennerz J.K., et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009, 457(7230):722-725.
16. Crellin N.K., Trifari S., Kaplan C.D., Cupedo T., Spits H. Human NKp44+ IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells. J. Exp. Med. 2010, 207(2):281-290.
17. Cupedo T., Crellin N.K., Papazian N., Rombouts E.J., Weijer K., Grogan J.L., et al. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat. Immunol. 2009, 10(1):66-74.
18. Lanier L., Le A.M., Civin C., Loken M., Phillips J. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J. Immunol. 1986, 136(12):4480-4486.
19. Vosshenrich C.A., García-Ojeda M.E., Samson-Villéger S.I., Pasqualetto V., Enault L., Richard-Le Goff O., et al. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat. Immunol. 2006, 7(11):1217-1224.
20. Cooper M.A., Fehniger T.A., Caligiuri M.A. The biology of human natural killer-cell subsets. Trends Immunol. 2001, 22(11):633-640.
21. Klose C.S., Flach M., Möhle L., Rogell L., Hoyler T., Ebert K., et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 2014, 157(2):340-356.
22. Bernink J.H., Peters C.P., Munneke M., te Velde A.A., Meijer S.L., Weijer K., et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat. Immunol. 2013, 14(3):221-229.
23. Fuchs A., Vermi W., Lee J.S., Lonardi S., Gilfillan S., Newberry R.D., et al. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12-and IL-15-responsive IFN-γ-producing cells. Immunity 2013, 38(4):769-781.
24. + innate lymphocytes. Immunity 2010, 33(5):736-751.
25. Koyasu S., Moro K. Role of innate lymphocytes in infection and inflammation. Front. Immunol. 2012, 3.
26. Monticelli L.A., Sonnenberg G.F., Abt M.C., Alenghat T., Ziegler C.G., Doering T.A., et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 2011, 12(11):1045-1054.
27. Eberl G., Marmon S., Sunshine M.-J., Rennert P.D., Choi Y., Littman D.R. An essential function for the nuclear receptor RORγt in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 2003, 5(1):64-73.
28. Mjösberg J.M., Trifari S., Crellin N.K., Peters C.P., van Drunen C.M., Piet B., et al. Human IL-25-and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat. Immunol. 2011, 12(11):1055-1062.
29. Kabata H., Moro K., Koyasu S., Asano K. Group 2 innate lymphoid cells and asthma. Allergol. Int. 2015.
30. Moro K., Yamada T., Tanabe M., Takeuchi T., Ikawa T., Kawamoto H., et al. Innate production of TH2 cytokines by adipose tissue-associated c-Kit+ Sca-1+ lymphoid cells. Nature 2010, 463(7280):540-544.
31. Neill D.R., Wong S.H., Bellosi A., Flynn R.J., Daly M., Langford T.K., et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010, 464(7293):1367-1370.
32. Saenz S.A., Siracusa M.C., Perrigoue J.G., Spencer S.P., Urban J.F., Tocker J.E., et al. IL25 elicits a multipotent progenitor cell population that promotes TH2 cytokine responses. Nature 2010, 464(7293):1362-1366.
33. Halim T.Y., Krauß R.H., Sun A.C., Takei F. Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 2012, 36(3):451-463.
34. Mjösberg J., Bernink J., Golebski K., Karrich J.J., Peters C.P., Blom B., et al. The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 2012, 37(4):649-659.
35. Fallon P.G., Ballantyne S.J., Mangan N.E., Barlow J.L., Dasvarma A., Hewett D.R., et al. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J. Exp. Med. 2006, 203(4):1105-1116.
36. Barlow J.L., Bellosi A., Hardman C.S., Drynan L.F., Wong S.H., Cruickshank J.P., et al. Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J. Allergy Clin. Immunol. 2012, 129(1):191-198. e4.
37. Sawa S., Cherrier M., Lochner M., Satoh-Takayama N., Fehling H.J., Langa F., et al. Lineage relationship analysis of RORγt+ innate lymphoid cells. Science 2010, 330(6004):665-669.
38. Mebius R.E., Streeter P.R., Michie S., Butcher E.C., Weissman I.L. A developmental switch in lymphocyte homing receptor and endothelial vascular address in expression regulates lymphocyte homing and permits CD4+ CD3-cells to colonize lymph nodes. Proc. Natl. Acad. Sci. 1996, 93(20):11019-11024.
39. Takatori H., Kanno Y., Watford W.T., Tato C.M., Weiss G., Ivanov I.I., et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J. Exp. Med. 2009, 206(1):35-41.
40. Satoh-Takayama N., Lesjean-Pottier S., Vieira P., Sawa S., Eberl G., Vosshenrich C.A., et al. IL-7 and IL-15 independently program the differentiation of intestinal CD3- NKp46+ cell subsets from Id2-dependent precursors. J. Exp. Med. 2010, 207(2):273-280.
41. Cherrier M., Sawa S., Eberl G. Notch, Id2, and RORγt sequentially orchestrate the fetal development of lymphoid tissue inducer cells. J. Exp. Med. 2012, 209(4):729-740.
42. Sonnenberg G.F., Monticelli L.A., Elloso M.M., Fouser L.A., Artis D. CD4+ lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 2011, 34(1):122-134.
43. Klose C.S., Kiss E.A., Schwierzeck V., Ebert K., Hoyler T., d'Hargues Y., et al. A T-bet gradient controls the fate and function of CCR6-ROR [ggr] t+ innate lymphoid cells. Nature 2013, 494(7436):261-265.
44. Luci C., Reynders A., Ivanov I.I., Cognet C., Chiche L., Chasson L., et al. Influence of the transcription factor RORγt on the development of NKp46+ cell populations in gut and skin. Nat. Immunol. 2009, 10(1):75-82.
45. Satoh-Takayama N., Vosshenrich C.A., Lesjean-Pottier S., Sawa S., Lochner M., Rattis F., et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 2008, 29(6):958-970.
46. Hazenberg M.D., Spits H. Human innate lymphoid cells. Blood 2014, 124(5):700-709.
47. Spits H., Di Santo J.P. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat. Immunol. 2011, 12(1):21-27.
48. Hoyler T., Klose C.S., Souabni A., Turqueti-Neves A., Pfeifer D., Rawlins E.L., et al. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 2012, 37(4):634-648.
49. Koyasu S., Moro K., Tanabe M., Takeuchi T. 2 natural helper cells: a new player in the innate immune response against Helminth infection. Adv. Immunol. 2010, 108:21.
50. Bouskra D., Brézillon C., Bérard M., Werts C., Varona R., Boneca I.G., et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 2008, 456(7221):507-510.
51. Scandella E., Bolinger B., Lattmann E., Miller S., Favre S., Littman D.R., et al. Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone. Nat. Immunol. 2008, 9(6):667-675.
52. Ouyang W., Kolls J.K., Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008, 28(4):454-467.
53. Sanos S.L., Diefenbach A. Innate lymphoid cells: from border protection to the initiation of inflammatory diseases. Immunol. Cell Biol. 2013, 91(3):215-224.
54. Kee B.L. E and ID proteins branch out. Nat. Rev. Immunol. 2009, 9(3):175-184.
55. Sanos S.L., Bui V.L., Mortha A., Oberle K., Heners C., Johner C., et al. RORγt and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat. Immunol. 2008, 10(1):83-91.
56. Wolk K., Witte E., Witte K., Warszawska K., Sabat R. Biology of interleukin-22. Semin. Immunopathol. 2010.
57. Kamizono S., Duncan G.S., Seidel M.G., Morimoto A., Hamada K., Grosveld G., et al. Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo. J. Exp. Med. 2009, 206(13):2977-2986.
58. Gascoyne D.M., Long E., Veiga-Fernandes H., de Boer J., Williams O., Seddon B., et al. The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nat. Immunol. 2009, 10(10):1118-1124.
59. Boos M.D., Yokota Y., Eberl G., Kee B.L. Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. J. Exp. Med. 2007, 204(5):1119-1130.
60. Ribeiro V.S., Hasan M., Wilson A., Boucontet L., Pereira P., Lesjean-Pottier S., et al. Cutting edge: thymic NK cells develop independently from T cell precursors. J. Immunol. 2010, 185(9):4993-4997.
61. Daussy C., Faure F., Mayol K., Viel S., Gasteiger G., Charrier E., et al. T-bet and EOMES instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow. J. Exp. Med. 2014, 211(3):563-577.
62. Wong S.H., Walker J.A., Jolin H.E., Drynan L.F., Hams E., Camelo A., et al. Transcription factor ROR [alpha] is critical for nuocyte development. Nat. Immunol. 2012, 13(3):229-236.
63. Gentek R., Munneke J.M., Helbig C., Blom B., Hazenberg M.D., Spits H., et al. Modulation of signal strength switches Notch from an inducer of T cells to an inducer of ILC2. Front. Immunol. 2013, 4.
64. Halim T.Y., MacLaren A., Romanish M.T., Gold M.J., McNagny K.M., Takei F. Retinoic-acid-receptor-related orphan nuclear receptor alpha is required for natural helper cell development and allergic inflammation. Immunity 2012, 37(3):463-474.
65. Spooner C.J., Lesch J., Yan D., Khan A.A., Abbas A., Ramirez-Carrozzi V., et al. Specification of type 2 innate lymphocytes by the transcriptional determinant Gfi1. Nat. Immunol. 2013, 14(12):1229-1236.
66. Walker J.A., Oliphant C.J., Englezakis A., Yu Y., Clare S., Rodewald H.-R., et al. Bcl11b is essential for group 2 innate lymphoid cell development. J. Exp. Med. 2015, 10.1084/jem.20142224.
67. Yu Y., Wang C., Clare S., Wang J., Lee S.-C., Brandt C., et al. The transcription factor Bcl11b is specifically expressed in group 2 innate lymphoid cells and is essential for their development. J. Exp. Med. 2015, 10.1084/jem.20142318.
68. Tachibana M., Tenno M., Tezuka C., Sugiyama M., Yoshida H., Taniuchi I. Runx1/Cbfβ2 complexes are required for lymphoid tissue inducer cell differentiation at two developmental stages. J. Immunol. 2011, 186(3):1450-1457.
69. Aliahmad P., de la Torre B., Kaye J. Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue-inducer cell and NK cell lineages. Nat. Immunol. 2010, 11(10):945-952.
70. Sciumé G., Hirahara K., Takahashi H., Laurence A., Villarino A.V., Singleton K.L., et al. Distinct requirements for T-bet in gut innate lymphoid cells. J. Exp. Med. 2012, 209(13):2331-2338.
71. Rankin L.C., Groom J.R., Chopin M., Herold M.J., Walker J.A., Mielke L.A., et al. The transcription factor T-bet is essential for the development of NKp46+ innate lymphocytes via the Notch pathway. Nat. Immunol. 2013, 14(4):389-395.
72. Cella M., Otero K., Colonna M. Expansion of human NK-22 cells with IL-7, IL-2, and IL-1β reveals intrinsic functional plasticity. Proc. Natl. Acad. Sci. 2010, 107(24):10961-10966.
73. Hughes T., Becknell B., Freud A.G., McClory S., Briercheck E., Yu J., et al. Interleukin-1β selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue. Immunity 2010, 32(6):803-814.
74. Sun J.C., Lanier L.L. NK cell development, homeostasis and function: parallels with CD8+ T cells. Nat. Rev. Immunol. 2011, 11(10):645-657.
75. Fallon P.G., Jolin H.E., Smith P., Emson C.L., Townsend M.J., Fallon R., et al. IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13. Immunity 2002, 17(1):7-17.
76. Finkelman F.D., Shea-Donohue T., Morris S.C., Gildea L., Strait R., Madden K.B., et al. Interleukin-4- and interleukin-13-mediated host protection against intestinal nematode parasites. Immunol. Rev. 2004, 201(1):139-155.
77. Kang Z., Swaidani S., Yin W., Wang C., Barlow J.L., Gulen M.F., et al. Epithelial cell-specific Act1 adaptor mediates interleukin-25-dependent helminth expulsion through expansion of Lin- c-Kit+ innate cell population. Immunity 2012, 36(5):821-833.
78. Licona-Limón P., Henao-Mejia J., Temann A.U., Gagliani N., Licona-Limón I., Ishigame H., et al. Th9 cells drive host immunity against gastrointestinal worm infection. Immunity 2013, 39(4):744-757.
79. Claudio E., Sønder S.U., Saret S., Carvalho G., Ramalingam T.R., Wynn T.A., et al. The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammation. J. Immunol. 2009, 182(3):1617-1630.
80. Zheng Y., Valdez P.A., Danilenko D.M., Hu Y., Sa S.M., Gong Q., et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 2008, 14(3):282-289.
81. Goto Y., Obata T., Kunisawa J., Sato S., Ivanov I.I., Lamichhane A., et al. Innate lymphoid cells regulate intestinal epithelial cell glycosylation. Science 2014, 345(6202):1254009.
82. Songhet P., Barthel M., Stecher B., Muller A., Kremer M., Hansson G.C., et al. Stromal IFN-gammaR-signaling modulates goblet cell function during Salmonella typhimurium infection. PLoS ONE 2011, 6(7):e22459.
83. Gladiator A., Wangler N., Trautwein-Weidner K., LeibundGut-Landmann S. Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection. J. Immunol. 2013, 190(2):521-525.
84. Conti H.R., Shen F., Nayyar N., Stocum E., Sun J.N., Lindemann M.J., et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J. Exp. Med. 2009, 206(2):299-311.
85. Kagami S., Rizzo H.L., Kurtz S.E., Miller L.S., Blauvelt A. IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans. J. Immunol. 2010, 185(9):5453-5462.
86. Deepe G.S., Gibbons R.S. Interleukins 17 and 23 influence the host response to Histoplasma capsulatum. J. Infect. Dis. 2009, 200(1):142-151.
87. Rudner X.L., Happel K.I., Young E.A., Shellito J.E. Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect. Immun. 2007, 75(6):3055-3061.
88. Werner J.L., Metz A.E., Horn D., Schoeb T.R., Hewitt M.M., Schwiebert L.M., et al. Requisite role for the dectin-1 β-glucan receptor in pulmonary defense against Aspergillus fumigatus. J. Immunol. 2009, 182(8):4938-4946.
89. Gladiator A., LeibundGut-Landmann S. Innate lymphoid cells: new players in IL-17-mediated antifungal immunity. PLoS Pathog. 2013, 9(12):e1003763.
90. Ballantyne S.J., Barlow J.L., Jolin H.E., Nath P., Williams A.S., Chung K.F., et al. Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. J. Allergy Clin. Immunol. 2007, 120(6):1324-1331.
91. Moffatt M.F., Gut I.G., Demenais F., Strachan D.P., Bouzigon E., Heath S., et al. A large-scale, consortium-based genomewide association study of asthma. N. Engl. J. Med. 2010, 363(13):1211-1221.
92. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23(5):479-490.
93. Barlow J.L., Peel S., Fox J., Panova V., Hardman C.S., Camelo A., et al. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J. Allergy Clin. Immunol. 2013, 132(4):933-941.
94. Saenz S.A., Siracusa M.C., Monticelli L.A., Ziegler C.G., Kim B.S., Brestoff J.R., et al. IL-25 simultaneously elicits distinct populations of innate lymphoid cells and multipotent progenitor type 2 (MPPtype2) cells. J. Exp. Med. 2013, 210(9):1823-1837.
95. Petersen B.C., Budelsky A.L., Baptist A.P., Schaller M.A., Lukacs N.W. Interleukin-25 induces type 2 cytokine production in a steroid-resistant interleukin-17RB+ myeloid population that exacerbates asthmatic pathology. Nat. Med. 2012, 18(5):751-758.
96. Warringa R., Schweizer R., Maikoe T., Kuijper P., Bruijnzeel P., Koendermann L. Modulation of eosinophil chemotaxis by interleukin-5. Am. J. Respir. Cell Mol. Biol. 1992, 7:631.
97. Shi H.-Z., Xiao C.-Q., Zhong D., Qin S.-M., Liu Y., Liang G.-R., et al. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics. Am. J. Respir. Crit. Care Med. 1998, 157(1):204-209.
98. Farahani R., Sherkat R., Hakemi M.G., Eskandari N., Yazdani R. Cytokines (interleukin-9, IL-17, IL-22, IL-25 and IL-33) and asthma. Adv. Biomed. Res. 2014, 3.
99. Wilhelm C., Turner J.-E., Van Snick J., Stockinger B. The many lives of IL-9: a question of survival [quest]. Nat. Immunol. 2012, 13(7):637-641.
100. Sherkat R., Yazdani R., Hakemi M.G., Homayouni V., Farahani R., Hosseini M., et al. Innate lymphoid cells and cytokines of the novel subtypes of helper T cells in asthma. Asia Pac. Allergy 2014, 4(4):212.
101. Wolterink R.G., KleinJan A., van Nimwegen M., Bergen I., de Bruijn M., Levani Y., et al. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Eur. J. Immunol. 2012, 42(5):1106-1116.
102. Salimi M., Barlow J.L., Saunders S.P., Xue L., Gutowska-Owsiak D., Wang X., et al. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J. Exp. Med. 2013, 210(13):2939-2950.
103. Kim B.S., Siracusa M.C., Saenz S.A., Noti M., Monticelli L.A., Sonnenberg G.F., et al. TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci. Transl. Med. 2013, 5(170):170ra16.
104. Imai Y., Yasuda K., Sakaguchi Y., Haneda T., Mizutani H., Yoshimoto T., et al. Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice. Proc. Natl. Acad. Sci. U.S.A. 2013, 110(34):13921-13926.
105. Salimi M., Ogg G. Innate lymphoid cells and the skin. BMC Dermatol. 2014, 14(1):18.
106. Jackson D.J., Sykes A., Mallia P., Johnston S.L. Asthma exacerbations: origin, effect, and prevention. J. Allergy Clin. Immunol. 2011, 128(6):1165-1174.
107. Chang Y.-J., Kim H.Y., Albacker L.A., Baumgarth N., McKenzie A.N., Smith D.E., et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat. Immunol. 2011, 12(7):631-638.
108. Eisenring M., vom Berg J., Kristiansen G., Saller E., Becher B. IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46. Nat. Immunol. 2010, 11(11):1030-1038.
109. Levy E.M., Roberti M.P., Mordoh J. Natural killer cells in human cancer: from biological functions to clinical applications. Biomed. Res. Int. 2011, 2011.
110. Kirchberger S., Royston D.J., Boulard O., Thornton E., Franchini F., Szabady R.L., et al. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J. Exp. Med. 2013, 210(5):917-931.
111. Huber S., Gagliani N., Zenewicz L.A., Huber F.J., Bosurgi L., Hu B., et al. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 2012, 491(7423):259-263.
112. Savan R., McFarland A.P., Reynolds D.A., Feigenbaum L., Ramakrishnan K., Karwan M., et al. A novel role for IL-22R1 as a driver of inflammation. Blood 2011, 117(2):575-584.
113. Park O., Wang H., Weng H., Feigenbaum L., Li H., Yin S., et al. In vivo consequences of liver-specific interleukin-22 expression in mice: implications for human liver disease progression. Hepatology 2011, 54(1):252-261.
114. Miyagaki T., Sugaya M., Suga H., Kamata M., Ohmatsu H., Fujita H., et al. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma. Clin. Cancer Res. 2011, 17(24):7529-7538.
115. Jiang R., Tan Z., Deng L., Chen Y., Xia Y., Gao Y., et al. Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3. Hepatology 2011, 54(3):900-909.
116. Chan I., Jain R., Tessmer M., Gorman D., Mangadu R., Sathe M., et al. Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells. Mucosal Immunol. 2014, 7(4):842-856.
117. Murugaiyan G., Saha B. Protumor vs antitumor functions of IL-17. J. Immunol. 2009, 183(7):4169-4175.
118. Galli S.J., Borregaard N., Wynn T.A. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat. Immunol. 2011, 12(11):1035-1044.
119. Buonocore S., Ahern P.P., Uhlig H.H., Ivanov I.I., Littman D.R., Maloy K.J., et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 2010, 464(7293):1371-1375.
120. Li L.-J., Gong C., Zhao M.-H., Feng B.-S. Role of interleukin-22 in inflammatory bowel disease. World J. Gastroenterol. 2014, 20(48):18177.
121. Powell N., Walker A.W., Stolarczyk E., Canavan J.B., Gökmen M.R., Marks E., et al. The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells. Immunity 2012, 37(4):674-684.
122. Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006, 314(5804):1461-1463.
123. Zaba L.C., Cardinale I., Gilleaudeau P., Sullivan-Whalen M., Suárez-Fariñas M., Fuentes-Duculan J., et al. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J. Exp. Med. 2007, 204(13):3183-3194.
124. Piskin G., Sylva-Steenland R.M., Bos J.D., Teunissen M.B. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. J. Immunol. 2006, 176(3):1908-1915.
125. Tonel G., Conrad C., Laggner U., Di Meglio P., Grys K., McClanahan T.K., et al. Cutting edge: a critical functional role for IL-23 in psoriasis. J. Immunol. 2010, 185(10):5688-5691.
126. Lee E., Trepicchio W.L., Oestreicher J.L., Pittman D., Wang F., Chamian F., et al. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J. Exp. Med. 2004, 199(1):125-130.
127. Wolk K., Witte E., Wallace E., Döcke W.D., Kunz S., Asadullah K., et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol. 2006, 36(5):1309-1323.
128. Griffiths C.E., Strober B.E., van de Kerkhof P., Ho V., Fidelus-Gort R., Yeilding N., et al. Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis. N. Engl. J. Med. 2010, 362(2):118-128.
129. Leonardi C., Matheson R., Zachariae C., Cameron G., Li L., Edson-Heredia E., et al. Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N. Engl. J. Med. 2012, 366(13):1190-1199.
130. Papp K.A., Leonardi C., Menter A., Ortonne J.-P., Krueger J.G., Kricorian G., et al. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N. Engl. J. Med. 2012, 366(13):1181-1189.
131. Dyring-Andersen B., Geisler C., Agerbeck C., Lauritsen J., Gudjonsdottir S., Skov L., et al. Increased number and frequency of group 3 innate lymphoid cells in nonlesional psoriatic skin. Br. J. Dermatol. 2014, 170(3):609-616.
132. Teunissen M.B., Munneke J.M., Bernink J.H., Spuls P.I., Velde A., Cheuk S., et al. Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR+ ILC3 in lesional skin and blood of psoriasis patients. J. Invest. Dermatol. 2014.
133. Villanova F., Flutter B., Tosi I., Grys K., Sreeneebus H., Perera G.K., et al. Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis. J. Invest. Dermatol. 2014, 134(4):984-991.
134. Cai Y., Shen X., Ding C., Qi C., Li K., Li X., et al. Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. Immunity 2011, 35(4):596-610.
135. Pantelyushin S., Haak S., Ingold B., Kulig P., Heppner F.L., Navarini A.A., et al. Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice. J. Clin. Invest. 2012, 122(6):2252-2256.
136. Hepworth M.R., Monticelli L.A., Fung T.C., Ziegler C.G., Grunberg S., Sinha R., et al. Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature 2013, 498(7452):113-117.
137. Hartgring S.A., van Roon J.A., Wijk M.W.V., Jacobs K.M., Jahangier Z.N., Willis C.R., et al. Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis. Arthritis Rheum. 2009, 60(9):2595-2605.
138. van Roon J.A., Verweij M.C., Wijk M.W.V., Jacobs K.M., Bijlsma J.W., Lafeber F.P. Increased intraarticular interleukin-7 in rheumatoid arthritis patients stimulates cell contact-dependent activation of CD4+ T cells and macrophages. Arthritis Rheum. 2005, 52(6):1700-1710.
139. Harada S., Yamamura M., Okamoto H., Morita Y., Kawashima M., Aita T., et al. Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum. 1999, 42(7):1508-1516.
140. Bekiaris V., Šedý J.R., Rossetti M., Spreafico R., Sharma S., Rhode-Kurnow A., et al. Human CD4+ CD3- innate-like T cells provide a source of TNF and lymphotoxin-αβ and are elevated in rheumatoid arthritis. J. Immunol. 2013, 191(9):4611-4618.
141. Takahashi H., Amagai M., Tanikawa A., Suzuki S., Ikeda Y., Nishikawa T., et al. T helper type 2-biased natural killer cell phenotype in patients with pemphigus vulgaris. J. Invest. Dermatol. 2007, 127(2):324-330.
142. Stern J., Keskin D., Barteneva N., Zuniga J., Yunis E., Ahmed A. Possible role of natural killer cells in pemphigus vulgaris - preliminary observations. Clin. Exp. Immunol. 2008, 152(3):472-481.
143. von Bubnoff D., Andrès E., Hentges F., Bieber T., Michel T., Zimmer J. Natural killer cells in atopic and autoimmune diseases of the skin. J. Allergy Clin. Immunol. 2010, 125(1):60-68.
144. Ganjalikhani-Hakemi M., Yazdani R., Sherkat R., Homayouni V., Masjedi M., Hosseini M. Evaluation of the T helper 17 cell specific genes and the innate lymphoid cells counts in the peripheral blood of patients with the common variable immunodeficiency. J. Res. Med. Sci. 2014, 19(Suppl. 1):S30.
145. Sedda S., Marafini I., Figliuzzi M.M., Pallone F., Monteleone G. An overview of the role of innate lymphoid cells in gut infections and inflammation. Mediators Inflamm. 2014, 2014.
146. Huntington N.D., Vosshenrich C.A., Di Santo J.P. Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nat. Rev. Immunol. 2007, 7(9):703-714.